Evofem Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(0.9%),Heights Capital Management, Inc.(0.9%)
Feb 14 15:37 ET
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Zhang Yan
Jan 12 00:00 ET
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Kamdar Kim P.
Dec 22, 2023 16:05 ET
Evofem Biosciences | D: Filing D
Oct 10, 2023 19:57 ET
Evofem Biosciences | 5: Annual statement of changes in beneficial ownership of securities-Chief Financial Officer File Justin J.
May 8, 2023 16:05 ET
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer PELLETIER SAUNDRA L
Apr 26, 2023 20:50 ET
Evofem Biosciences | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Zhang Yan
Apr 26, 2023 20:48 ET
Evofem Biosciences | D: Filing D
Mar 6, 2023 14:48 ET
Evofem Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(5.5%),Heights Capital Management, Inc.(5.5%)
Feb 14, 2023 11:24 ET
Evofem Biosciences | D: Filing D
Feb 3, 2023 17:02 ET
Evofem Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Todd Stewart Cox(0%),Kathy Overstreet Cox(0%)
Aug 10, 2022 16:17 ET
Evofem Biosciences | 3: Initial statement of beneficial ownership of securities
Aug 8, 2022 17:26 ET
Evofem Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Todd Stewart Cox(9.29%),Kathy Overstreet Cox(9.29%)
Jul 19, 2022 16:31 ET
Evofem Biosciences | 3: Initial statement of beneficial ownership of securities-Chief Commercial Officer Atkinson Katherine Cocca
Jun 7, 2022 08:45 ET
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
May 31, 2022 08:55 ET
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
May 6, 2022 16:10 ET
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
May 6, 2022 16:10 ET
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
May 6, 2022 16:09 ET
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
May 6, 2022 16:09 ET
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
May 6, 2022 16:08 ET
No Data
No Data